Pharmacovigilance Software-Europe Market Status and Trend Report 2013-2023
Report Summary
Pharmacovigilance Software-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pharmacovigilance Software industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Pharmacovigilance Software 2013-2017, and development forecast 2018-2023
Main market players of Pharmacovigilance Software in Europe, with company and product introduction, position in the Pharmacovigilance Software market
Market status and development trend of Pharmacovigilance Software by types and applications
Cost and profit status of Pharmacovigilance Software, and marketing status
Market growth drivers and challenges
The report segments the Europe Pharmacovigilance Software market as:
Europe Pharmacovigilance Software Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Pharmacovigilance Software Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Issue Tracking Software
Fully Integrated Software
Adverse Event Reporting Software
Drug Safety Audits Software
Europe Pharmacovigilance Software Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Business Process Outsourcing (BPO) Firms
Contract Research Organizations (CROS)
Pharma & Biotech Companies
Others
Europe Pharmacovigilance Software Market: Players Segment Analysis (Company and Product introduction, Pharmacovigilance Software Sales Volume, Revenue, Price and Gross Margin):
United Biosource Corporation
Umbra Global
Sparta Systems, Inc
Sarjen Systems Pvt. Ltd
Oracle Corporation.
Online Business Applications, Inc
Extedo GMBH.
Ennov.
Arisglobal
AB-Cube
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Pharmacovigilance Software-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pharmacovigilance Software industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Pharmacovigilance Software 2013-2017, and development forecast 2018-2023
Main market players of Pharmacovigilance Software in Europe, with company and product introduction, position in the Pharmacovigilance Software market
Market status and development trend of Pharmacovigilance Software by types and applications
Cost and profit status of Pharmacovigilance Software, and marketing status
Market growth drivers and challenges
The report segments the Europe Pharmacovigilance Software market as:
Europe Pharmacovigilance Software Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Pharmacovigilance Software Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Issue Tracking Software
Fully Integrated Software
Adverse Event Reporting Software
Drug Safety Audits Software
Europe Pharmacovigilance Software Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Business Process Outsourcing (BPO) Firms
Contract Research Organizations (CROS)
Pharma & Biotech Companies
Others
Europe Pharmacovigilance Software Market: Players Segment Analysis (Company and Product introduction, Pharmacovigilance Software Sales Volume, Revenue, Price and Gross Margin):
United Biosource Corporation
Umbra Global
Sparta Systems, Inc
Sarjen Systems Pvt. Ltd
Oracle Corporation.
Online Business Applications, Inc
Extedo GMBH.
Ennov.
Arisglobal
AB-Cube
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PHARMACOVIGILANCE SOFTWARE
1.1 Definition of Pharmacovigilance Software in This Report
1.2 Commercial Types of Pharmacovigilance Software
1.2.1 Issue Tracking Software
1.2.2 Fully Integrated Software
1.2.3 Adverse Event Reporting Software
1.2.4 Drug Safety Audits Software
1.3 Downstream Application of Pharmacovigilance Software
1.3.1 Business Process Outsourcing (BPO) Firms
1.3.2 Contract Research Organizations (CROS)
1.3.3 Pharma & Biotech Companies
1.3.4 Others
1.4 Development History of Pharmacovigilance Software
1.5 Market Status and Trend of Pharmacovigilance Software 2013-2023
1.5.1 Europe Pharmacovigilance Software Market Status and Trend 2013-2023
1.5.2 Regional Pharmacovigilance Software Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pharmacovigilance Software in Europe 2013-2017
2.2 Consumption Market of Pharmacovigilance Software in Europe by Regions
2.2.1 Consumption Volume of Pharmacovigilance Software in Europe by Regions
2.2.2 Revenue of Pharmacovigilance Software in Europe by Regions
2.3 Market Analysis of Pharmacovigilance Software in Europe by Regions
2.3.1 Market Analysis of Pharmacovigilance Software in Germany 2013-2017
2.3.2 Market Analysis of Pharmacovigilance Software in United Kingdom 2013-2017
2.3.3 Market Analysis of Pharmacovigilance Software in France 2013-2017
2.3.4 Market Analysis of Pharmacovigilance Software in Italy 2013-2017
2.3.5 Market Analysis of Pharmacovigilance Software in Spain 2013-2017
2.3.6 Market Analysis of Pharmacovigilance Software in Benelux 2013-2017
2.3.7 Market Analysis of Pharmacovigilance Software in Russia 2013-2017
2.4 Market Development Forecast of Pharmacovigilance Software in Europe 2018-2023
2.4.1 Market Development Forecast of Pharmacovigilance Software in Europe 2018-2023
2.4.2 Market Development Forecast of Pharmacovigilance Software by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Pharmacovigilance Software in Europe by Types
3.1.2 Revenue of Pharmacovigilance Software in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Pharmacovigilance Software in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pharmacovigilance Software in Europe by Downstream Industry
4.2 Demand Volume of Pharmacovigilance Software by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pharmacovigilance Software by Downstream Industry in Germany
4.2.2 Demand Volume of Pharmacovigilance Software by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Pharmacovigilance Software by Downstream Industry in France
4.2.4 Demand Volume of Pharmacovigilance Software by Downstream Industry in Italy
4.2.5 Demand Volume of Pharmacovigilance Software by Downstream Industry in Spain
4.2.6 Demand Volume of Pharmacovigilance Software by Downstream Industry in Benelux
4.2.7 Demand Volume of Pharmacovigilance Software by Downstream Industry in Russia
4.3 Market Forecast of Pharmacovigilance Software in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PHARMACOVIGILANCE SOFTWARE
5.1 Europe Economy Situation and Trend Overview
5.2 Pharmacovigilance Software Downstream Industry Situation and Trend Overview
CHAPTER 6 PHARMACOVIGILANCE SOFTWARE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Pharmacovigilance Software in Europe by Major Players
6.2 Revenue of Pharmacovigilance Software in Europe by Major Players
6.3 Basic Information of Pharmacovigilance Software by Major Players
6.3.1 Headquarters Location and Established Time of Pharmacovigilance Software Major Players
6.3.2 Employees and Revenue Level of Pharmacovigilance Software Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PHARMACOVIGILANCE SOFTWARE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 United Biosource Corporation
7.1.1 Company profile
7.1.2 Representative Pharmacovigilance Software Product
7.1.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of United Biosource Corporation
7.2 Umbra Global
7.2.1 Company profile
7.2.2 Representative Pharmacovigilance Software Product
7.2.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of Umbra Global
7.3 Sparta Systems, Inc
7.3.1 Company profile
7.3.2 Representative Pharmacovigilance Software Product
7.3.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of Sparta Systems, Inc
7.4 Sarjen Systems Pvt. Ltd
7.4.1 Company profile
7.4.2 Representative Pharmacovigilance Software Product
7.4.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of Sarjen Systems Pvt. Ltd
7.5 Oracle Corporation.
7.5.1 Company profile
7.5.2 Representative Pharmacovigilance Software Product
7.5.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of Oracle Corporation.
7.6 Online Business Applications, Inc
7.6.1 Company profile
7.6.2 Representative Pharmacovigilance Software Product
7.6.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of Online Business Applications, Inc
7.7 Extedo GMBH.
7.7.1 Company profile
7.7.2 Representative Pharmacovigilance Software Product
7.7.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of Extedo GMBH.
7.8 Ennov.
7.8.1 Company profile
7.8.2 Representative Pharmacovigilance Software Product
7.8.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of Ennov.
7.9 Arisglobal
7.9.1 Company profile
7.9.2 Representative Pharmacovigilance Software Product
7.9.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of Arisglobal
7.10 AB-Cube
7.10.1 Company profile
7.10.2 Representative Pharmacovigilance Software Product
7.10.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of AB-Cube
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHARMACOVIGILANCE SOFTWARE
8.1 Industry Chain of Pharmacovigilance Software
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PHARMACOVIGILANCE SOFTWARE
9.1 Cost Structure Analysis of Pharmacovigilance Software
9.2 Raw Materials Cost Analysis of Pharmacovigilance Software
9.3 Labor Cost Analysis of Pharmacovigilance Software
9.4 Manufacturing Expenses Analysis of Pharmacovigilance Software
CHAPTER 10 MARKETING STATUS ANALYSIS OF PHARMACOVIGILANCE SOFTWARE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Pharmacovigilance Software in This Report
1.2 Commercial Types of Pharmacovigilance Software
1.2.1 Issue Tracking Software
1.2.2 Fully Integrated Software
1.2.3 Adverse Event Reporting Software
1.2.4 Drug Safety Audits Software
1.3 Downstream Application of Pharmacovigilance Software
1.3.1 Business Process Outsourcing (BPO) Firms
1.3.2 Contract Research Organizations (CROS)
1.3.3 Pharma & Biotech Companies
1.3.4 Others
1.4 Development History of Pharmacovigilance Software
1.5 Market Status and Trend of Pharmacovigilance Software 2013-2023
1.5.1 Europe Pharmacovigilance Software Market Status and Trend 2013-2023
1.5.2 Regional Pharmacovigilance Software Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pharmacovigilance Software in Europe 2013-2017
2.2 Consumption Market of Pharmacovigilance Software in Europe by Regions
2.2.1 Consumption Volume of Pharmacovigilance Software in Europe by Regions
2.2.2 Revenue of Pharmacovigilance Software in Europe by Regions
2.3 Market Analysis of Pharmacovigilance Software in Europe by Regions
2.3.1 Market Analysis of Pharmacovigilance Software in Germany 2013-2017
2.3.2 Market Analysis of Pharmacovigilance Software in United Kingdom 2013-2017
2.3.3 Market Analysis of Pharmacovigilance Software in France 2013-2017
2.3.4 Market Analysis of Pharmacovigilance Software in Italy 2013-2017
2.3.5 Market Analysis of Pharmacovigilance Software in Spain 2013-2017
2.3.6 Market Analysis of Pharmacovigilance Software in Benelux 2013-2017
2.3.7 Market Analysis of Pharmacovigilance Software in Russia 2013-2017
2.4 Market Development Forecast of Pharmacovigilance Software in Europe 2018-2023
2.4.1 Market Development Forecast of Pharmacovigilance Software in Europe 2018-2023
2.4.2 Market Development Forecast of Pharmacovigilance Software by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Pharmacovigilance Software in Europe by Types
3.1.2 Revenue of Pharmacovigilance Software in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Pharmacovigilance Software in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pharmacovigilance Software in Europe by Downstream Industry
4.2 Demand Volume of Pharmacovigilance Software by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pharmacovigilance Software by Downstream Industry in Germany
4.2.2 Demand Volume of Pharmacovigilance Software by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Pharmacovigilance Software by Downstream Industry in France
4.2.4 Demand Volume of Pharmacovigilance Software by Downstream Industry in Italy
4.2.5 Demand Volume of Pharmacovigilance Software by Downstream Industry in Spain
4.2.6 Demand Volume of Pharmacovigilance Software by Downstream Industry in Benelux
4.2.7 Demand Volume of Pharmacovigilance Software by Downstream Industry in Russia
4.3 Market Forecast of Pharmacovigilance Software in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PHARMACOVIGILANCE SOFTWARE
5.1 Europe Economy Situation and Trend Overview
5.2 Pharmacovigilance Software Downstream Industry Situation and Trend Overview
CHAPTER 6 PHARMACOVIGILANCE SOFTWARE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Pharmacovigilance Software in Europe by Major Players
6.2 Revenue of Pharmacovigilance Software in Europe by Major Players
6.3 Basic Information of Pharmacovigilance Software by Major Players
6.3.1 Headquarters Location and Established Time of Pharmacovigilance Software Major Players
6.3.2 Employees and Revenue Level of Pharmacovigilance Software Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PHARMACOVIGILANCE SOFTWARE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 United Biosource Corporation
7.1.1 Company profile
7.1.2 Representative Pharmacovigilance Software Product
7.1.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of United Biosource Corporation
7.2 Umbra Global
7.2.1 Company profile
7.2.2 Representative Pharmacovigilance Software Product
7.2.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of Umbra Global
7.3 Sparta Systems, Inc
7.3.1 Company profile
7.3.2 Representative Pharmacovigilance Software Product
7.3.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of Sparta Systems, Inc
7.4 Sarjen Systems Pvt. Ltd
7.4.1 Company profile
7.4.2 Representative Pharmacovigilance Software Product
7.4.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of Sarjen Systems Pvt. Ltd
7.5 Oracle Corporation.
7.5.1 Company profile
7.5.2 Representative Pharmacovigilance Software Product
7.5.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of Oracle Corporation.
7.6 Online Business Applications, Inc
7.6.1 Company profile
7.6.2 Representative Pharmacovigilance Software Product
7.6.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of Online Business Applications, Inc
7.7 Extedo GMBH.
7.7.1 Company profile
7.7.2 Representative Pharmacovigilance Software Product
7.7.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of Extedo GMBH.
7.8 Ennov.
7.8.1 Company profile
7.8.2 Representative Pharmacovigilance Software Product
7.8.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of Ennov.
7.9 Arisglobal
7.9.1 Company profile
7.9.2 Representative Pharmacovigilance Software Product
7.9.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of Arisglobal
7.10 AB-Cube
7.10.1 Company profile
7.10.2 Representative Pharmacovigilance Software Product
7.10.3 Pharmacovigilance Software Sales, Revenue, Price and Gross Margin of AB-Cube
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHARMACOVIGILANCE SOFTWARE
8.1 Industry Chain of Pharmacovigilance Software
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PHARMACOVIGILANCE SOFTWARE
9.1 Cost Structure Analysis of Pharmacovigilance Software
9.2 Raw Materials Cost Analysis of Pharmacovigilance Software
9.3 Labor Cost Analysis of Pharmacovigilance Software
9.4 Manufacturing Expenses Analysis of Pharmacovigilance Software
CHAPTER 10 MARKETING STATUS ANALYSIS OF PHARMACOVIGILANCE SOFTWARE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
